GMAB
Genmab AS
34.80$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.9% | -86.9% | +0.0% | +828.3% | -83.9% | -12.1% | -78.4% | +764.7% | -44.0% | -99.0% | +1,593.7% | – | |
| – | -31.8% | -77.6% | +7.7% | +700.0% | -88.4% | +23.2% | 0.0% | +12.5% | +16.7% | +38.1% | -10.3% | – | |
| – | -5.6% | -84.3% | +12.5% | +588.9% | -89.0% | +22.2% | +32.0% | +3.1% | +5.9% | +36.1% | -24.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -23.8% | -263.9% | – | – | +369.8% | -240.0% | – | +12,561.4% | -144.8% | – | – | |
| – | -31.6% | -94.0% | +0.0% | +1,100.0% | -43.8% | +11.2% | -66.7% | -80.0% | +549.3% | -61.4% | -40.2% | – | |
| – | -143.8% | -52.5% | +504.8% | – | -49.1% | -137.7% | – | -307.7% | +10,226.5% | -99.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.0% | +1,216.7% | +454.4% | -32.9% | – | -307.9% | +390.3% | -94.1% | – | -22,140.5% | -100.0% | – | |
| – | – | – | – | – | – | -424.7% | +100.0% | +25.0% | -60.0% | +3,350.0% | -5.8% | – | |
| – | -210.0% | +286.4% | +417.6% | -37.3% | – | -132.0% | +3,022.4% | -94.8% | – | -103.4% | -57.8% | – | |
| – | -82.5% | -113.0% | – | – | -78.8% | -43.8% | -235.1% | – | -109.9% | – | – | – | |
| – | -17.2% | -86.6% | +0.0% | +823.3% | -84.9% | -14.2% | -79.8% | +927.1% | -46.2% | -100.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.